BioNTech to return €2bn to shareholders on back of Covid vaccine success 0 30.03.2022 15:28 Financial Times German biotech plans to boost R&D spending by 50% as quarterly earnings beat forecasts Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
